Stifel Financial Corp Intra Cellular Therapies, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 33,212 shares of ITCI stock, worth $4.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,212

Previous 33,241 0.09%

Holding current value

$4.22 Million

Previous $2.28 Million 6.68%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.99 - $80.84 $1,971 - $2,344	-29 Reduced 0.09%	33,212 $2.43 Million
Q2 2024 Aug 13, 2024	SELL	$64.76 - $79.84 $14,700 - $18,123	-227 Reduced 0.68%	33,241 $2.28 Million
Q1 2024 May 13, 2024	SELL	$64.37 - $75.65 $9,848 - $11,574	-153 Reduced 0.46%	33,468 $2.32 Million
Q4 2023 Feb 12, 2024	BUY	$46.37 - $73.65 $5,749 - $9,132	124 Added 0.37%	33,621 $2.41 Million
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $126,630 - $155,827	-2,431 Reduced 6.77%	33,497 $1.74 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $2,514 - $3,056	46 Added 0.13%	35,928 $2.27 Million
Q1 2023 May 12, 2023	SELL	$43.8 - $56.99 $43 - $56	-1 Reduced -0.0%	35,882 $1.94 Million
Q4 2022 Feb 13, 2023	SELL	$44.07 - $54.45 $10,709 - $13,231	-243 Reduced 0.67%	35,883 $1.9 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $128 - $179	3 Added 0.01%	36,126 $1.68 Million
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $193,543 - $295,445	-4,501 Reduced 11.08%	36,123 $2.06 Million
Q1 2022 May 13, 2022	SELL	$38.74 - $62.09 $56,444 - $90,465	-1,457 Reduced 3.46%	40,624 $2.49 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $32,032 - $48,612	-910 Reduced 2.12%	42,081 $2.2 Million
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $92,507 - $136,860	3,221 Added 8.1%	42,991 $1.6 Million
Q2 2021 Aug 13, 2021	SELL	$29.3 - $44.5 $12,686 - $19,268	-433 Reduced 1.08%	39,770 $1.62 Million
Q1 2021 May 14, 2021	BUY	$30.8 - $39.51 $291,676 - $374,159	9,470 Added 30.81%	40,203 $1.36 Million
Q4 2020 Feb 12, 2021	SELL	$23.34 - $32.22 $34,473 - $47,588	-1,477 Reduced 4.59%	30,733 $977,000
Q3 2020 Nov 16, 2020	SELL	$17.61 - $31.86 $34,691 - $62,764	-1,970 Reduced 5.76%	32,210 $827,000
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $253,851 - $471,261	17,690 Added 107.28%	34,180 $877,000
Q1 2020 May 14, 2020	BUY	$12.31 - $33.12 $30,959 - $83,296	2,515 Added 18.0%	16,490 $254,000
Q4 2019 Feb 13, 2020	BUY	$7.26 - $38.49 $3,448 - $18,282	475 Added 3.52%	13,975 $479,000
Q3 2019 Nov 13, 2019	SELL	$7.47 - $14.03 $8,964 - $16,836	-1,200 Reduced 8.16%	13,500 $101,000
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $5,198 - $7,020	300 Added 2.08%	14,700 $260,000
Q4 2017 Feb 14, 2018	SELL	$14.27 - $16.79 $6,421 - $7,555	-450 Reduced 3.03%	14,400 $209,000
Q3 2017 Nov 13, 2017	BUY	$10.77 - $22.1 $159,934 - $328,185	14,850	14,850 $0

Others Institutions Holding ITCI

# of Institutions

381

Shares Held

84M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Intra Cellular Therapies, Inc. Transaction History